Millrace Asset Group Inc. bought a new stake in RTI Surgical Inc (NASDAQ:RTIX) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 129,920 shares of the medical equipment provider’s stock, valued at approximately $598,000. Millrace Asset Group Inc. owned approximately 0.20% of RTI Surgical as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Municipal Employees Retirement System of Michigan acquired a new position in shares of RTI Surgical in the first quarter worth about $892,000. Renaissance Technologies LLC grew its stake in RTI Surgical by 7.2% in the 4th quarter. Renaissance Technologies LLC now owns 1,311,455 shares of the medical equipment provider’s stock valued at $5,377,000 after buying an additional 87,900 shares during the last quarter. SG Americas Securities LLC acquired a new position in RTI Surgical in the 4th quarter valued at about $113,000. Schwab Charles Investment Management Inc. grew its stake in RTI Surgical by 16.1% in the 4th quarter. Schwab Charles Investment Management Inc. now owns 108,300 shares of the medical equipment provider’s stock valued at $445,000 after buying an additional 15,000 shares during the last quarter. Finally, Allianz Asset Management GmbH grew its stake in RTI Surgical by 69.0% in the 4th quarter. Allianz Asset Management GmbH now owns 398,085 shares of the medical equipment provider’s stock valued at $1,632,000 after buying an additional 162,525 shares during the last quarter. Institutional investors own 67.57% of the company’s stock.
RTI Surgical traded down $0.05, hitting $4.75, during midday trading on Wednesday, MarketBeat Ratings reports. The stock had a trading volume of 183 shares, compared to its average volume of 116,786. The firm has a market capitalization of $304.45 million, a price-to-earnings ratio of 95.00, a P/E/G ratio of 3.20 and a beta of 1.59. RTI Surgical Inc has a 52-week low of $3.85 and a 52-week high of $6.00. The company has a current ratio of 3.81, a quick ratio of 1.53 and a debt-to-equity ratio of 0.31.
RTI Surgical (NASDAQ:RTIX) last released its earnings results on Thursday, May 3rd. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.01. The company had revenue of $69.89 million during the quarter, compared to analyst estimates of $68.70 million. RTI Surgical had a net margin of 2.57% and a return on equity of 2.49%. analysts predict that RTI Surgical Inc will post 0.1 EPS for the current year.
A number of equities research analysts have commented on RTIX shares. Zacks Investment Research upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Wednesday, May 2nd. BidaskClub cut shares of RTI Surgical from a “hold” rating to a “sell” rating in a research note on Friday, April 20th. Finally, Craig Hallum raised shares of RTI Surgical from a “hold” rating to a “buy” rating in a research note on Friday, March 2nd.
RTI Surgical Company Profile
RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.